February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Ipilimumab and Nivolumab for patients with unresected advanced Hepatocellular Carcinoma – ESMO
Jul 5, 2024, 02:30

Ipilimumab and Nivolumab for patients with unresected advanced Hepatocellular Carcinoma – ESMO

ESMO shared on LinkedIn:

“Benefits reported for the combination of ipilimumab and nivolumab further expand alternative therapeutic options for patients with unresected advanced Hepatocellular Carcinoma.
Read the opinion piece by Angela Lamarca on ESMO Daily Reporter.”

Source: ESMO/LinkedIn

.